BGIM
TXMD icon

Brandywine Global Investment Management’s TherapeuticsMD TXMD Stock Holding History

Brandywine Global Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,378
Closed -$755K – 738
2021
Q3 		$755K Buy
+20,378
New +$904K 0.01% 584

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brandywine Global Investment Management's TXMD Position: Q4 2021 in Review

Brandywine Global Investment Management sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 20,378 shares — an estimated $755K sold.

Brandywine Global Investment Management first reported a position in TXMD in Q3 2021 and held it in 1 quarter. The position peaked at $755K in Q3 2021. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Brandywine Global Investment Management reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Brandywine Global Investment Management sold 20,378 TherapeuticsMD shares in Q4 2021, an estimated $755K.
  • Brandywine Global Investment Management first reported a position in TherapeuticsMD in Q3 2021 and held it in 1 quarter.
  • Brandywine Global Investment Management's TherapeuticsMD position peaked at $755K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Brandywine Global Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.